文献速递冠心病外科

减少目标导向抗凝下阿司匹林或双联抗血小板治疗患者CABG术后出血

Postoperative bleeding in myocardial revascularization under cardiopulmonary bypass for patients treated with aspirin or dual antiplatelet therapy using reduced goal-directed anticoagulation.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

该回顾性队列经倾向性匹配纳入2275例行CABG患者,比较双联抗血小板治疗(DAPT)与单用阿司匹林(ASA)在减少目标导向抗凝(目标ACT 250秒)下的严重出血风险。DAPT组严重出血评分虽显著高于ASA组,但所有评分严重出血率均低于6%,死亡率组间无显著差异。

要点

  • 减少目标导向抗凝下CABG术后严重出血率低(各评分<6%)。
  • DAPT组严重出血评分显著高于ASA组(UDPB P=0.016,E-CABG P=0.006)。
  • 最大ACT越高,输血和出血风险越高(P<0.001)。

核心结论

  • 尽管DAPT较ASA单药出血更多,减少目标导向抗凝的优化体外循环使CABG术后严重出血保持在低水平。

研究设计与样本

  • 回顾性队列研究,从3018例CABG患者经倾向性匹配选取2275例,DAPT组1111例,ASA组1164例。

主要发现

  • 所有出血评分严重出血率均低于6%,但DAPT组显著高于ASA组(UDPB P=0.016,E-CABG P=0.006,BARC-4 P=0.063)。
  • 多因素校正后,最大ACT越高与输血率(P<0.001)和出血率(P<0.001)越高相关。
  • 死亡率DAPT组1.24% vs ASA组0.94%(P=NS),心脏死亡、心肌梗死、卒中及短暂性脑缺血发作均低于1%且组间相似。

关键数值与推荐

  • 优化体外循环在减少全身抗凝下进行,目标激活凝血时间(ACT)为250秒。
  • 严重出血采用UDPB、E-CABG和BARC-4三种经验证评分评估。

临床怎么用

  • 对于接受DAPT或ASA的CABG患者,采用减少目标导向抗凝(目标ACT 250秒)的优化体外循环可降低严重出血风险。
  • 术中应监测最大ACT,避免过高ACT以降低输血和出血风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Antiplatelet therapy increases the risk of bleeding and transfusion in patients undergoing extracorporeal circulation. Reduced goal-directed anticoagulation is a personalized approach to reduce the anticoagulation based on a lower targeted activated clotting time. We assessed whether reduced goal-directed anticoagulation using optimized extracorporeal circulation alleviates the risk of severe bleeding in patients treated by dual antiplatelet therapy (DAPT) compared to aspirin alone during coronary artery bypass grafting (CABG). METHODS: A total of 2275 patients undergoing CABG from 2002 to 2022 were selected after propensity matching from a retrospective cohort of 3018 patients. Patients treated with a combination of aspirin and prasugrel or ticagrelor or clopidogrel were included in the DAPT group (n = 1111). Patients treated with aspirin alone (ASA) constituted the control group (n = 1164). Optimized extracorporeal circulation was conducted under reduced systemic anticoagulation with a target activated clotting time 250 s. Severe bleeding was assessed using 3 validated scores of bleeding: UDPB, E-CABG, and BARC-4. RESULTS: While all scores showed low ranges of severe bleeding (<6%), they were significantly higher after DAPT compared to ASA (P values for UDPB, E-CABG, and BARC-4 at 0.016, 0.006, and 0.063, respectively). Higher maximal activated clotting time was associated with higher rate of transfusion (P < 0.001) and bleeding (P < 0.001) after multivariate adjustment. Mortality was 1.24% in DAPT vs 0.94% in ASA group (P = NS), whereas cardiac death, myocardial infarction, stroke, and transient ischaemic attack were low (<1%) and similar between groups. CONCLUSIONS: Despite higher bleeding under DAPT compared to ASA alone, optimized extracorporeal circulation with reduced goal-directed anticoagulation alleviated severe bleeding which remained low in patients undergoing CABG.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Eid M, Dang Van S, Hamon Y, et al. Postoperative bleeding in myocardial revascularization under cardiopulmonary bypass for patients treated with aspirin or dual antiplatelet therapy using reduced goal-directed anticoagulation. Eur J Cardiothorac Surg. 2024. PMID: 39673458. doi:10.1093/ejcts/ezae436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。